BMS Extends Lonza Contract

19:43 PM | March 21, 2007 | Alex Scott

Bristol-Myers Squibb (BMS) says it has agreed to extend a supply agreement with Lonza, in which Lonza will manufacture BMS’s biologic rheumatoid arthritis drug Orencia until 2014. Orencia was approved...